These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27789032)

  • 1. Improving Biopharmaceutical Properties of Vinpocetine Through Cocrystallization.
    Golob S; Perry M; Lusi M; Chierotti MR; Grabnar I; Lassiani L; Voinovich D; Zaworotko MJ
    J Pharm Sci; 2016 Dec; 105(12):3626-3633. PubMed ID: 27789032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
    Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
    Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits.
    Xu H; He L; Nie S; Guan J; Zhang X; Yang X; Pan W
    J Control Release; 2009 Nov; 140(1):61-8. PubMed ID: 19651165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced oral bioavailability of vinpocetine through mechanochemical salt formation: physico-chemical characterization and in vivo studies.
    Hasa D; Voinovich D; Perissutti B; Grassi M; Bonifacio A; Sergo V; Cepek C; Chierotti MR; Gobetto R; Dall'Acqua S; Invernizzi S
    Pharm Res; 2011 Aug; 28(8):1870-83. PubMed ID: 21424156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
    Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X
    Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical Cocrystal: A Novel Approach to Tailor the Biopharmaceutical Properties of a Poorly Water Soluble Drug.
    Srivastava D; Fatima Z; Kaur CD; Tulsankar SL; Nashik SS; Rizvi DA
    Recent Pat Drug Deliv Formul; 2019; 13(1):62-69. PubMed ID: 30848223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
    Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the solubility of dexlansoprazole by cocrystallization with isonicotinamide.
    Li J; Wang L; Ye YQ; Fu X; Ren Q; Zhang H; Deng Z
    Eur J Pharm Sci; 2016 Mar; 85():47-52. PubMed ID: 26836368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and comparative bioavailability of two vinpocetine tablet formulations in healthy volunteers by using the metabolite apovincaminic acid as pharmacokinetic parameter.
    Vlase L; Bodiu B; Leucuta SE
    Arzneimittelforschung; 2005; 55(11):664-8. PubMed ID: 16366040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excipient-assisted vinpocetine nanoparticles: experiments and molecular dynamic simulations.
    Li CX; Wang HB; Oppong D; Wang JX; Chen JF; Le Y
    Mol Pharm; 2014 Nov; 11(11):4023-35. PubMed ID: 25244002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
    Li Z; Matzger AJ
    Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinpocetine pharmacokinetics in elderly subjects.
    Grandt R; Beitinger H; Schaltenbrand R; Braun W
    Arzneimittelforschung; 1989 Dec; 39(12):1599-602. PubMed ID: 2624613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glibenclamide-malonic acid cocrystal with an enhanced solubility and bioavailability.
    Srivastava D; Fatima Z; Kaur CD; Mishra A; Nashik SS; Rizvi DA; Prasad R
    Drug Dev Ind Pharm; 2022 Aug; 48(8):417-424. PubMed ID: 36073946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine.
    Cui SX; Nie SF; Li L; Wang CG; Pan WS; Sun JP
    Drug Dev Ind Pharm; 2009 May; 35(5):603-11. PubMed ID: 19040178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coformer selection in pharmaceutical cocrystal development: a case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics.
    Cheney ML; Weyna DR; Shan N; Hanna M; Wojtas L; Zaworotko MJ
    J Pharm Sci; 2011 Jun; 100(6):2172-81. PubMed ID: 21491441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclodextrin multicomponent complexation and controlled release delivery strategies to optimize the oral bioavailability of vinpocetine.
    Ribeiro LS; Falcão AC; Patrício JA; Ferreira DC; Veiga FJ
    J Pharm Sci; 2007 Aug; 96(8):2018-28. PubMed ID: 17530626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs.
    Song S; Tian B; Chen F; Zhang W; Pan Y; Zhang Q; Yang X; Pan W
    Drug Dev Ind Pharm; 2015 Jan; 41(1):51-62. PubMed ID: 24111828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalein-nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailability.
    Huang Y; Zhang B; Gao Y; Zhang J; Shi L
    J Pharm Sci; 2014 Aug; 103(8):2330-7. PubMed ID: 24903146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion.
    Boksa K; Otte A; Pinal R
    J Pharm Sci; 2014 Sep; 103(9):2904-2910. PubMed ID: 24807421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans.
    Miskolczi P; Kozma K; Polgár M; Vereczkey L
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):1-5. PubMed ID: 2384112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.